17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJHM, van Eyck J, Groenwold RHH, Hasaart THM, Hummel P, Kars MM, Kwee A, van Oirschot CM, van Pampus MG, Papatsonis D, Porath MM, Spaanderman ME, Willekes C, Wilpshaar J, Mol BWJ, Bruinse HW.
Lim AC, et al. Among authors: hummel p.
Obstet Gynecol. 2011 Sep;118(3):513-520. doi: 10.1097/AOG.0b013e31822ad6aa.
Obstet Gynecol. 2011.
PMID: 21860279
Clinical Trial.